Literature DB >> 641137

Long-term preservation of ischemic myocardium after experimental coronary artery occlusion.

D Maclean, M C Fishbein, E Braunwald, P R Maroko.   

Abstract

The results of experiments with indirect methods have suggested that various interventions reduce infarct size after coronary artery occlusion. To determine and quantify directly both the short- and long-term effects of several interventions on myocardial salvage without relying on indirect methods, the left coronary artery was occluded in 880 rats; they were then given either no treatment or one of the following interventions: (a) hyaluronidase, an enzyme that hydrolyzes interstitial glycoproteins, 1,500 National Formulary (NF) U/kg i.v. 5 min and 24 h after occlusion; (b) cobra venom factor, a protein that depletes the third component of complement, 20 U/kg i.v. 5 min after occlusion; (c) a glucocorticoid: hydrocortisone, 50 mg/kg i.v. 5 min after occlusion; or the five-fold more potent methylprednisolone (MP): (i) 50 mg/kg i.v. 5 min after occlusion or (ii) 50 mg/kg i.v. 5 min after occlusion followed by 50 mg/kg i.m. 3, 6, and 24 h after occlusion; or (d) reserpine, an agent that depletes the heart of catecholamines, 0.5 mg/kg i.m. once on each of the 3 days before occlusion. The animals were sacrificed either 2 days after occlusion, i.e., at the time of peak necrosis, or after 3 wk, i.e., after the infarct was completely healed. The amount of preserved myocardium was then assessed by two independent techniques: planimetric measurement of serial histologic sections and creatine kinase activity of the whole left ventricle. The amount of normal myocardium preserved at 21 days postocclusion was significantly increased, by 22.3+/-7.8% (P < 0.025) after the administration of hyaluronidase, by 25.3+/-5.8% (P < 0.005) after cobra venom factor, by 14.5+/-6.9% (P < 0.05) after hydrocortisone, by 20.8+/-8.2% (P < 0.025) after the single dose of MP, by 20.9+/-3.9% (P < 0.001) after the four doses of MP, and by 10.2+/-3.7% (P < 0.05) as a result of pretreatment with reserpine. The four doses of MP significantly thinned the infarct-by 25.6+/-2.9% (P < 0.001)-and although ventricular rupture did not occur, the intervention caused distension of the left ventricle as a result of stretching of the infarcted tissue during scar formation. Thus, myocardium acutely jeopardized by ischemia can be preserved on a long-term basis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 641137      PMCID: PMC372566          DOI: 10.1172/JCI108965

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  TIME RELATIONSHIP BETWEEN ADMINISTRATION OF CORTISONE AND WOUND HEALING IN RATS.

Authors:  N SANDBERG
Journal:  Acta Chir Scand       Date:  1964-05

2.  Principles and methods for the morphometric study of the lung and other organs.

Authors:  E R WEIBEL
Journal:  Lab Invest       Date:  1963-02       Impact factor: 5.662

3.  Simple techniques for the surgical occlusion of coronary vessels in the rat.

Authors:  H SELYE; E BAJUSZ; S GRASSO; P MENDELL
Journal:  Angiology       Date:  1960-10       Impact factor: 3.619

4.  Cardiac hypertrophy after coronary artery ligation in rats.

Authors:  T D NORMAN; C R COERS
Journal:  Arch Pathol       Date:  1960-02

5.  The pharmacology of Rauwolfia.

Authors:  H J BEIN
Journal:  Pharmacol Rev       Date:  1956-09       Impact factor: 25.468

6.  Experimental myocardial infarction. I. A method of coronary occlusion in small animals.

Authors:  T N P JOHNS; B J OLSON
Journal:  Ann Surg       Date:  1954-11       Impact factor: 12.969

7.  The influence of the time interval between coronary artery occlusion and the administration of hyaluronidase on salvage of ischemic myocardium in dogs.

Authors:  L D Hillis; M C Fishbein; E Braunwald; P R Maroko
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

8.  Quantitative study of infarcted myocardium in cardiogenic shock.

Authors:  C Harnarayan; M A Bennett; B L Pentecost; D B Brewer
Journal:  Br Heart J       Date:  1970-11

9.  Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog.

Authors:  W M Vogel; V G Zannoni; G D Abrams; B R Lucchesi
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

10.  Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction.

Authors:  P R Maroko; L D Hillis; J E Muller; L Tavazzi; G R Heyndrickx; M Ray; M Chiariello; A Distante; J Askenazi; J Salerno; J Carpentier; N I Reshetnaya; P Radvany; P Libby; D S Raabe; E I Chazov; P Bobba; E Braunwald
Journal:  N Engl J Med       Date:  1977-04-21       Impact factor: 91.245

View more
  23 in total

1.  Cardiomyopathy is linked to complement activation.

Authors:  Marina Afanasyeva; Noel R Rose
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

2.  The erythrocyte as instigator of inflammation. Generation of amidated C3 by erythrocyte adenosine deaminase.

Authors:  M K Hostetter; G M Johnson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  Systemic and regional vascular effects of atrial natriuretic peptide in a rat model of chronic heart failure.

Authors:  H Drexler; M Finkh; S Höing; M Toth; H Just; R E Lang
Journal:  Basic Res Cardiol       Date:  1987 Nov-Dec       Impact factor: 17.165

Review 4.  Non-invasive assessment of the effects of drugs on acute myocardial infarct size in man.

Authors:  D Maclean
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

Review 5.  Why Is Infarct Expansion Such an Elusive Therapeutic Target?

Authors:  William J Richardson; Jeffrey W Holmes
Journal:  J Cardiovasc Transl Res       Date:  2015-09-21       Impact factor: 4.132

Review 6.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

7.  Production of cardiac lesions with tyramine in intact rats. Studies on serum and myocardial creatine kinase activity changes and ultrastructural aspects.

Authors:  A Genovese; M Chiariello; W De Alfieri; S Latte; M Condorelli
Journal:  Basic Res Cardiol       Date:  1983 May-Jun       Impact factor: 17.165

8.  Influence of hyaluronidase on infarct size following experimental coronary occlusion of short (90') or long (24 hrs) duration.

Authors:  M Hofmann; M Hofmann; W Schaper
Journal:  Basic Res Cardiol       Date:  1980 Mar-Apr       Impact factor: 17.165

9.  Delay of development of transmural irreversible ischaemic injury in canine myocardium.

Authors:  P K Kirchner; P Alpers; M Hofmann; M Gottwik; J Schaper
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

Review 10.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.